05.09.2019
- The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021. One important driver is the trend towards outsourcing of development and manu...
05.09.2019
- The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021. One important driver is the trend towards outsourcing of development and manu...
16.07.2019
- The 34th and, so far, biggest edition of Chemspec Europe attracted a total of 4,295 trade visitors from 53 countries to the exhibition grounds of Messe Basel, Switzerland. During...
14.03.2019
- BP, Virent and Johnson Matthey have agreed to collaborate to further progress the commercialization of Virent’s Bioforming process for producing bio-paraxylene (PX), a key raw...
19.09.2018
- Recently, the pharmaceutical contract development and manufacturing organization (CDMO) industry has been extremely active in M&A, as is the pharma and generics industry itself...
28.02.2018
- ChemSpec Europe 2018: The Fine and Specialty Chemicals exhibition, taking place 20 – 21 June 2018 at Koelnmesse in Cologne, Germany, is known for being a key marketplace for...
- UK specialty chemical and technology group Johnson Matthey announced the successful scale-up and commercial availability of a novel Gusev catalyst for ester hydrogenation. Using...
27.09.2017
- 2017 marks the 200th anniversary of UK specialty chemical and technology group Johnson Matthey which – back in 1817 – began as assayers, testing the purity of precious metals. In...
